Results per Page:
Sharing AI insights without sharing patient data
Fred Hutch Q&A about leading alliance to leverage power of artificial intelligence responsibly in research and care
Balancing innovation and human insight: navigating the promise and limitations of AI in cancer research
From the Gary Lyman research group, Public Health Sciences Division
Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Bridging the gap between cancer drug target and cancer drug
Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches
Knowing your risk for inherited cancers matters
Take advantage of year-end family gatherings to discuss health history
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
The present and future of science intersect in Seattle
Highlights from the annual meeting of the American Association for the Advancement of Science
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations